Ignite Creation Date:
2025-12-24 @ 3:23 PM
Ignite Modification Date:
2026-01-01 @ 9:44 PM
Study NCT ID:
NCT04713592
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2021-01-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-20
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-13
First Submit QC Date:
None
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-18
Results First Submit QC Date:
None
Results First Post Date:
2024-06-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL